Cargando…
Thyroiditis After COVID-19 mRNA Vaccine: A Case Series
BACKGROUND: Although SARS-CoV-2 virus infection has been reported to cause subacute thyroiditis, the mRNA vaccine for SARS-CoV-2 is suspected to induce thyroiditis with thyrotoxicosis. CASE REPORT: : We describe 3 patients with no history of thyroid disease who presented with symptomatic, biochemica...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association of Clinical Endocrinology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675183/ https://www.ncbi.nlm.nih.gov/pubmed/34934810 http://dx.doi.org/10.1016/j.aace.2021.12.002 |
_version_ | 1784615828906311680 |
---|---|
author | Pandya, Manthan Thota, Geethika Wang, Xiangbing Luo, Hongxiu |
author_facet | Pandya, Manthan Thota, Geethika Wang, Xiangbing Luo, Hongxiu |
author_sort | Pandya, Manthan |
collection | PubMed |
description | BACKGROUND: Although SARS-CoV-2 virus infection has been reported to cause subacute thyroiditis, the mRNA vaccine for SARS-CoV-2 is suspected to induce thyroiditis with thyrotoxicosis. CASE REPORT: : We describe 3 patients with no history of thyroid disease who presented with symptomatic, biochemical, and radiological evidence of thyroiditis with thyrotoxicosis, 10 to 20 days after receiving either Pfizer Bio-NTech or Moderna COVID-19 mRNA vaccines. All patients presented with thyrotoxicosis but with negative thyroid-stimulating immunoglobulins for Graves disease and no autonomous nodules. Two patients underwent thyroid uptake scans that confirmed thyroiditis. One patient had significantly increased erythrocyte sedimentation rate and interleukin-6. All patients showed improvement in symptoms with nonsteroidal anti-inflammatory drugs, and 1 patient eventually required steroids for symptom control. DISCUSSION: The mRNA vaccine for SARS-CoV-2 was associated with thyroiditis and led to thyrotoxicosis. Elevated proinflammatory markers and cytokines after vaccines may play a major role. CONCLUSION: Our case series report highlights a possible relationship between the COVID-19 mRNA vaccine and thyroiditis with thyrotoxicosis, which has not been recognized by health providers. |
format | Online Article Text |
id | pubmed-8675183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Association of Clinical Endocrinology |
record_format | MEDLINE/PubMed |
spelling | pubmed-86751832021-12-17 Thyroiditis After COVID-19 mRNA Vaccine: A Case Series Pandya, Manthan Thota, Geethika Wang, Xiangbing Luo, Hongxiu AACE Clin Case Rep Case Report BACKGROUND: Although SARS-CoV-2 virus infection has been reported to cause subacute thyroiditis, the mRNA vaccine for SARS-CoV-2 is suspected to induce thyroiditis with thyrotoxicosis. CASE REPORT: : We describe 3 patients with no history of thyroid disease who presented with symptomatic, biochemical, and radiological evidence of thyroiditis with thyrotoxicosis, 10 to 20 days after receiving either Pfizer Bio-NTech or Moderna COVID-19 mRNA vaccines. All patients presented with thyrotoxicosis but with negative thyroid-stimulating immunoglobulins for Graves disease and no autonomous nodules. Two patients underwent thyroid uptake scans that confirmed thyroiditis. One patient had significantly increased erythrocyte sedimentation rate and interleukin-6. All patients showed improvement in symptoms with nonsteroidal anti-inflammatory drugs, and 1 patient eventually required steroids for symptom control. DISCUSSION: The mRNA vaccine for SARS-CoV-2 was associated with thyroiditis and led to thyrotoxicosis. Elevated proinflammatory markers and cytokines after vaccines may play a major role. CONCLUSION: Our case series report highlights a possible relationship between the COVID-19 mRNA vaccine and thyroiditis with thyrotoxicosis, which has not been recognized by health providers. American Association of Clinical Endocrinology 2021-12-16 /pmc/articles/PMC8675183/ /pubmed/34934810 http://dx.doi.org/10.1016/j.aace.2021.12.002 Text en © 2022 AACE. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Pandya, Manthan Thota, Geethika Wang, Xiangbing Luo, Hongxiu Thyroiditis After COVID-19 mRNA Vaccine: A Case Series |
title | Thyroiditis After COVID-19 mRNA Vaccine: A Case Series |
title_full | Thyroiditis After COVID-19 mRNA Vaccine: A Case Series |
title_fullStr | Thyroiditis After COVID-19 mRNA Vaccine: A Case Series |
title_full_unstemmed | Thyroiditis After COVID-19 mRNA Vaccine: A Case Series |
title_short | Thyroiditis After COVID-19 mRNA Vaccine: A Case Series |
title_sort | thyroiditis after covid-19 mrna vaccine: a case series |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675183/ https://www.ncbi.nlm.nih.gov/pubmed/34934810 http://dx.doi.org/10.1016/j.aace.2021.12.002 |
work_keys_str_mv | AT pandyamanthan thyroiditisaftercovid19mrnavaccineacaseseries AT thotageethika thyroiditisaftercovid19mrnavaccineacaseseries AT wangxiangbing thyroiditisaftercovid19mrnavaccineacaseseries AT luohongxiu thyroiditisaftercovid19mrnavaccineacaseseries |